Happy New Year – 2016

It’s been an interesting year. When I started this site I really didn’t know what was going to happen… in most respects, it has exceeded my expectations. A Few Opening Remarks On a positive note, I genuinely felt support for the mission of trying to create a fresh dialogue around the quality and transparency of ASX-listed companies operating in this…

Because an Emu Wouldn’t Fit in the Oven…

One of my great hopes for the Australian biosciences scene is that we get to a stage of market information quality that retail investors can read and use a critical assessment of a biotech stock, and actually take note rather than just get their knickers in a twist. It requires many ecosystem changes but if we want to…

Back Online

Dear Tailgaters, After a couple of interesting weeks, the site is back up. It was really frustrating for me to have to take the site down but I elected to be cautious. Since the start of this project, I’ve had periodic aggression, but mostly from companies that, quite frankly, don’t have the financial resources to…

Good MAAAAAAWNIN’ Sydney!

Good maaaaaawning Stuart Roberts in Sydney, Let me start this email by asking you, Prima BioMed, a question. Are you optimistic about the state of the world at the moment, or pessimistic? Me, I’m pessimistic, indeed, I’ve been particularly pessimistic ever since I watched your stock rally on the basis of yesterday’s sensationalist drivel. I couldn’t…

Clinical Trial Communication Matters

Over the past few months I have poked several companies in the eye for the appalling quality of their clinical communication. I have specifically paid attention to Novogen (ASX : NRT), Benitec (ASX : BLT), Regeneus (ASX : RGS) and a few others. It is my position is that there is a consistently low quality and sensationalist ethos…

Neuren – A Can of Worms

Firstly, I would like to start this post by promoting another blog – specifically Trail to a Texas Trial. For anyone who is passionate about Rett Syndrome, it is powerful and emotional reading. I received a rather scathing retort from Melinda Lancaster, the owner of the site and the mother of a girl named Katelin who is…